Insider Buying: The Biotech Growth Trust PLC (LON:BIOG) Insider Buys £27,930 in Stock

The Biotech Growth Trust PLC (LON:BIOGGet Free Report) insider Hamish Baillie purchased 3,000 shares of the business’s stock in a transaction on Wednesday, November 27th. The stock was purchased at an average cost of GBX 931 ($11.86) per share, for a total transaction of £27,930 ($35,575.09).

The Biotech Growth Trust Stock Down 0.5 %

LON:BIOG opened at GBX 965 ($12.29) on Friday. The company has a current ratio of 0.33, a quick ratio of 0.00 and a debt-to-equity ratio of 13.03. The Biotech Growth Trust PLC has a twelve month low of GBX 741 ($9.44) and a twelve month high of GBX 1,068.36 ($13.61). The company has a market cap of £310.05 million, a PE ratio of 466.18 and a beta of 0.50. The company’s 50 day moving average is GBX 1,002.92 and its two-hundred day moving average is GBX 1,000.08.

About The Biotech Growth Trust

(Get Free Report)

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations.

Read More

Receive News & Ratings for The Biotech Growth Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Biotech Growth Trust and related companies with MarketBeat.com's FREE daily email newsletter.